0 results available. Select is focused ,type to refine list, press Down to open the menu,
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the...
The following section summarizes insights on Roche Holding AG Participation's Capital Expenditures Margin:
We've identified the following companies as similar to Roche Holding AG Participation because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
| Name | Ticker | Capital Expenditures Margin |
|---|---|---|
| H. Lundbeck A/S | DB:LDBB | 2.3% |
| AstraZeneca PLC | BRSE:000982352 | 3.6% |
| Sanofi SA | ENXTPA:SAN | 3.9% |
| Healthcare | SECTOR:HLTH.CH | 4.3% |
| GlaxoSmithKline PLC | BRSE:001102657 | 4.5% |
| Johnson & Johnson | BRSE:000943981 | 5.0% |
| Merck & Co., Inc. | BRSE:010683053 | 5.3% |
| Roche Holding AG Participation | LSE:0QOK | 5.7% |
| Bayer AG | SWX:BAYN | 6.0% |
| Merck KGaA | BRSE:MER | 8.0% |
| Novo Nordisk A/S | BRSE:NOVOB | 16.2% |
| Lonza Group AG | SWX:LONN | 21.6% |
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Capital Expenditures Margin in the efficiency category include:
Capital expenditures expressed as percent of revenue.
The capital expenditures margin measures a company’s capital expenditures as a percentage of the revenue. The formula to calculate capital expenditures margin and an example calculation for Roche’s trailing twelve months is outlined below:
Capital Expenditures Margin = Capital Expenditures / Total Revenue
5.7% = 3.529 B / 62.395 B
The tables below summarizes Roche’s performance over the last five years:
| Fiscal Year | Capital Expenditures | Revenue | Margin |
|---|---|---|---|
| 2020-12-31 | 3.528 B | 60.343 B | 5.8% |
| 2021-12-31 | 3.693 B | 65.85 B | 5.6% |
| 2022-12-31 | 3.449 B | 65.814 B | 5.2% |
| 2023-12-31 | 3.742 B | 60.441 B | 6.2% |
| 2024-12-31 | 3.529 B | 62.395 B | 5.7% |
The tables below summarizes Roche’s performance over the last four quarters:
| Quarter Ending | Capital Expenditures | Revenue | Margin |
|---|---|---|---|
| 2024-03-31 | 862 M | 15.378 B | 5.6% |
| 2024-06-30 | 862 M | 15.378 B | 5.6% |
| 2024-09-30 | 902.5 M | 15.819 B | 5.7% |
| 2024-12-31 | 902.5 M | 15.819 B | 5.7% |
You can read more about Capital Expenditures here.
The chart above depicts the distribution of capital expenditures margin for companies operating in the Healthcare sector in the Developed economic region. Over 2,005 companies were considered in this analysis, and 1,945 had meaningful values. The average capital expenditures margin of companies in the sector is 7.7% with a standard deviation of 23.8%.
Roche Holding AG Participation's Capital Expenditures Margin of 5.7% ranks in the 76.9% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,010 |
| Included Constituents | 1,945 |
| Min | 0.0% |
| Max | 255.8% |
| Median | 1.5% |
| Mean | 7.7% |
| Standard Deviation | 23.8% |
You can find companies with similar capital expenditures margin using this stock screener.